Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record, with a small difference in title or year; 58 of the 58 references it cites were found in a registry or an index.

Effects of Initiating Moderate Alcohol Intake on Cardiometabolic Risk in Adults With Type 2 Diabetes: A 2-Year Randomized, Controlled Trial

Abstract

BACKGROUND: Recommendations for moderate alcohol consumption remain controversial, particularly in type 2 diabetes mellitus (T2DM). Long-term randomized, controlled trials (RCTs) are lacking. OBJECTIVE: To assess cardiometabolic effects of initiating moderate alcohol intake in persons with T2DM and whether the type of wine matters. DESIGN: 2-year RCT (CASCADE [CArdiovaSCulAr Diabetes & Ethanol] trial). (ClinicalTrials.gov: NCT00784433). SETTING: Ben-Gurion University of the Negev-Soroka Medical Center and Nuclear Research Center Negev, Israel. PATIENTS: Alcohol-abstaining adults with well-controlled T2DM. INTERVENTION: Patients were randomly assigned to 150 mL of mineral water, white wine, or red wine with dinner for 2 years. Wines and mineral water were provided. All groups followed a Mediterranean diet without caloric restriction. MEASUREMENTS: Primary outcomes were lipid and glycemic control profiles. Genetic measurements were done, and patients were followed for blood pressure, liver biomarkers, medication use, symptoms, and quality of life. RESULTS: Of the 224 patients who were randomly assigned, 94% had follow-up data at 1 year and 87% at 2 years. In addition to the changes in the water group (Mediterranean diet only), red wine significantly increased high-density lipoprotein cholesterol (HDL-C) level by 0.05 mmol/L (2.0 mg/dL) (95% CI, 0.04 to 0.06 mmol/L [1.6 to 2.2 mg/dL]; P < 0.001) and apolipoprotein(a)1 level by 0.03 g/L (CI, 0.01 to 0.06 g/L; P = 0.05) and decreased the total cholesterol-HDL-C ratio by 0.27 (CI, -0.52 to -0.01; P = 0.039). Only slow ethanol metabolizers (alcohol dehydrogenase alleles [ADH1B*1] carriers) significantly benefited from the effect of both wines on glycemic control (fasting plasma glucose, homeostatic model assessment of insulin resistance, and hemoglobin A1c) compared with fast ethanol metabolizers (persons homozygous for ADH1B*2). Across the 3 groups, no material differences were identified in blood pressure, adiposity, liver function, drug therapy, symptoms, or quality of life, except that sleep quality improved in both wine groups compared with the water group (P = 0.040). Overall, compared with the changes in the water group, red wine further reduced the number of components of the metabolic syndrome by 0.34 (CI, -0.68 to -0.001; P = 0.049). LIMITATION: Participants were not blinded to treatment allocation. CONCLUSION: This long-term RCT suggests that initiating moderate wine intake, especially red wine, among well-controlled diabetics as part of a healthy diet is apparently safe and modestly decreases cardiometabolic risk. The genetic interactions suggest that ethanol plays an important role in glucose metabolism, and red wine's effects also involve nonalcoholic constituents. PRIMARY FUNDING SOURCE: European Foundation for the Study of Diabetes.

Overview

Integrity signals

Registry

Crossref · 10.7326/m14-1650

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 58 references

Research works printed but not linked: 3

  1. DeFronzo RA, 1979, Am J Physiol, 237, E214
  2. 10.1111/j.1530-0277.2001.tb02242.x · doi:10.1111/j.1530-0277.2001.tb02242.x · Paper page
  3. Edenberg HJ, 2007, Alcohol Res Health, 30, 5

Cited by

See all 196

Metadata

Authors
Gepner, Y., Golan, R., Harman-Boehm, I., Henkin, Y., Schwarzfuchs, D., Shelef, I., Durst, R., Kovsan, J., Bolotin, A., Leitersdorf, E., Shpitzen, S., Balag, S., Shemesh, E., Witkow, S., Tangi-Rosental, O., Chassidim, Y., Liberty, I. F., Sarusi, B., Ben-Avraham, S., Helander, A., Ceglarek, U., Stumvoll, M., Blüher, M., Thiery, J., Rudich, A., Stampfer, M. J., & Shai, I.
Affiliations
  • Ben-Gurion University of the Negev (IL)
  • From Ben-Gurion University of the Negev and Soroka Medical Center, Beer Sheva, Israel; Nuclear Research Center Negev, Dimona, Israel; Hadassah Hebrew University Medical Center, Jerusalem, Israel; Karolinska Institute, Solna, Sweden; University of Leipzig, Leipzig, Germany; and Brigham and Women's Hospital and Harvard School of Public Health, Boston, Massachusetts.
Venue
Annals of Internal Medicine
Published
2015-10-20
Volume
163
Issue
8
Pages
569-579
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2153685590
Cited by
196
References
58
Citations by year
2026: 7 · 2025: 14 · 2024: 14 · 2023: 15 · 2022: 22 · 2021: 18 · 2020: 18 · 2019: 13 · 2018: 15 · 2017: 21 · 2016: 30 · 2015: 8
FWCI
19.57
Type
journal article
Language
en
Open access
closed
Locations
  • Annals of Internal Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
type 2 diabetes, moderate drinking, red wine, white wine, cardiometabolic risk, HDL cholesterol, apolipoprotein(a), TC/HDL-C ratio, glycemic control, insulin resistance, Mediterranean diet, alcohol abstinence, liver enzymes
MeSH terms
Alcohol Dehydrogenase, Alcohol Drinking, Blood Glucose, Diabetes Mellitus, Type 2, Female, Genotype, Glycated Hemoglobin, Humans, Insulin Resistance, Lipids, Liver, Male, Middle Aged, Patient Compliance, Quality of Life, Risk Factors, Wine, Biomarkers, Diet, Mediterranean, Adiposity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of Initiating Moderate Alcohol Intake on Cardiometabolic Risk in Adults With Type 2 Diabetes: A 2-Year Randomized, Controlled Trial. https://app.cochat.ai/papers/10.7326/m14-1650
The paper
Gepner, Y., Golan, R., Harman-Boehm, I., Henkin, Y., Schwarzfuchs, D., Shelef, I., Durst, R., Kovsan, J., Bolotin, A., Leitersdorf, E., Shpitzen, S., Balag, S., Shemesh, E., Witkow, S., Tangi-Rosental, O., Chassidim, Y., Liberty, I. F., Sarusi, B., Ben-Avraham, S., . . . Shai, I. (2015). Effects of Initiating Moderate Alcohol Intake on Cardiometabolic Risk in Adults With Type 2 Diabetes: A 2-Year Randomized, Controlled Trial. Annals of Internal Medicine. https://doi.org/10.7326/m14-1650

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.